Venuti MC[au] - Search Results

Year	Number of Results
1979	1
1986	2
1987	4
1988	3
1989	1
1991	1
2005	1
2008	1
2022	0

1

Venuti MC. Venuti MC. Mol Genet Med. 1991;1:133-67. doi: 10.1016/b978-0-12-462001-8.50010-7. Mol Genet Med. 1991. PMID: 1842571 Review. No abstract available.

2

The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K.

Gauthier JY, Chauret N, Cromlish W, Desmarais S, Duong LT, Falgueyret JP, Kimmel DB, Lamontagne S, Léger S, LeRiche T, Li CS, Massé F, McKay DJ, Nicoll-Griffith DA, Oballa RM, Palmer JT, Percival MD, Riendeau D, Robichaud J, Rodan GA, Rodan SB, Seto C, Thérien M, Truong VL, Venuti MC, Wesolowski G, Young RN, Zamboni R, Black WC. Gauthier JY, et al. Among authors: venuti mc. Bioorg Med Chem Lett. 2008 Feb 1;18(3):923-8. doi: 10.1016/j.bmcl.2007.12.047. Epub 2008 Jan 15. Bioorg Med Chem Lett. 2008. PMID: 18226527

3

Topical nonsteroidal antipsoriatic agents. 1. 1,2,3,4-Tetraoxygenated naphthalene derivatives.

Jones GH, Venuti MC, Young JM, Murthy DV, Loe BE, Simpson RA, Berks AH, Spires DA, Maloney PJ, Kruseman M, et al. Jones GH, et al. Among authors: venuti mc. J Med Chem. 1986 Aug;29(8):1504-11. doi: 10.1021/jm00158a031. J Med Chem. 1986. PMID: 3016268

4

Topical nonsteroidal antipsoriatic agents. 2. 2,3-(Alkylidenedioxy)naphthalene analogues of lonapalene.

Venuti MC, Loe BE, Jones GH, Young JM. Venuti MC, et al. J Med Chem. 1988 Nov;31(11):2132-6. doi: 10.1021/jm00119a013. J Med Chem. 1988. PMID: 3141623

5

Design and synthesis of tri-ring P3 benzamide-containing aminonitriles as potent, selective, orally effective inhibitors of cathepsin K.

Palmer JT, Bryant C, Wang DX, Davis DE, Setti EL, Rydzewski RM, Venkatraman S, Tian ZQ, Burrill LC, Mendonca RV, Springman E, McCarter J, Chung T, Cheung H, Janc JW, McGrath M, Somoza JR, Enriquez P, Yu ZW, Strickley RM, Liu L, Venuti MC, Percival MD, Falgueyret JP, Prasit P, Oballa R, Riendeau D, Young RN, Wesolowski G, Rodan SB, Johnson C, Kimmel DB, Rodan G. Palmer JT, et al. Among authors: venuti mc. J Med Chem. 2005 Dec 1;48(24):7520-34. doi: 10.1021/jm058198r. J Med Chem. 2005. PMID: 16302794

6

Inhibitors of cyclic AMP phosphodiesterase. 1. Analogues of cilostamide and anagrelide.

Jones GH, Venuti MC, Alvarez R, Bruno JJ, Berks AH, Prince A. Jones GH, et al. Among authors: venuti mc. J Med Chem. 1987 Feb;30(2):295-303. doi: 10.1021/jm00385a011. J Med Chem. 1987. PMID: 3027338

7

Synthesis and biological evaluation of omega-(N,N,N-trialkylammonium)alkyl esters and thioesters of carboxylic acid nonsteroidal antiinflammatory agents.

Venuti MC, Young JM, Maloney PJ, Johnson D, McGreevy K. Venuti MC, et al. Pharm Res. 1989 Oct;6(10):867-73. doi: 10.1023/a:1015960522189. Pharm Res. 1989. PMID: 2608628

8

Inhibitors of cyclic AMP phosphodiesterase. 3. Synthesis and biological evaluation of pyrido and imidazolyl analogues of 1,2,3,5-tetrahydro-2-oxoimidazo[2,1-b]quinazoline.

Venuti MC, Stephenson RA, Alvarez R, Bruno JJ, Strosberg AM. Venuti MC, et al. J Med Chem. 1988 Nov;31(11):2136-45. doi: 10.1021/jm00119a014. J Med Chem. 1988. PMID: 2846839

9

Inhibitors of cyclic AMP phosphodiesterase. 2. Structural variations of N-cyclohexyl-N-methyl-4-[(1,2,3,5-tetrahydro- 2-oxoimidazo[2,1-b]quinazolin-7-yl)-oxy]butyramide (RS-82856).

Venuti MC, Jones GH, Alvarez R, Bruno JJ. Venuti MC, et al. J Med Chem. 1987 Feb;30(2):303-18. doi: 10.1021/jm00385a012. J Med Chem. 1987. PMID: 3027339

10

A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties.

Alvarez R, Banerjee GL, Bruno JJ, Jones GL, Littschwager K, Strosberg AM, Venuti MC. Alvarez R, et al. Among authors: venuti mc. Mol Pharmacol. 1986 Jun;29(6):554-60. Mol Pharmacol. 1986. PMID: 3012320

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results